Submission Details

Submitter:

Classification:
Definitive
GENCC:100001
Gene:
Disease:
childhood hypophosphatasia
Mode Of Inheritance:
Autosomal recessive
Evaluated Date:
01/21/2019
Evidence/Notes:

ALPL has been described in association with autosomal recessive moderate hypophosphatasia (Taillandier et al., 2000; PMID:10679946). Moderate hypophosphatasia is a rare, moderate form of hypophosphatasia characterized by defective mineralization of bone and/or teeth, premature loss of teeth with intact roots, and reduced serum alkaline phosphatase (ALP) activity. Individuals can present with this form of hypophosphatasia in infancy, childhood, or adulthood. Based upon the severity and mode of inheritance of the hypophosphatasia clinical subtypes, the curations for autosomal recessive severe hypophosphatasia, autosomal dominant moderate hypophosphatasia, and autosomal dominant mild hypophosphatasia have been split and curated separately (PMID: 32973344). Eighteen variants (missense, splice, frameshift) that have been reported in 12 probands in 3 publications (PMIDs: 10679946, 25731960, 32160374) are included in this curation. More evidence is available in the literature but the maximum score for genetic evidence (12 pts.) has been reached. The mechanism of disease is reported to be loss of function. This gene-disease association is also supported by an animal model (PMID: 30446691). In summary, ALPL is definitively associated with autosomal recessive moderate hypophosphatasia. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Skeletal Disorders GCEP on the meeting date 1/19/21 (SOP Version 8).

PubMed IDs:
10679946 25731960 30446691 32160374
Public Report:
Assertion Criteria:
Submitter Submitted Date:
12/05/2025

The GenCC data are available free of restriction under a CC0 1.0 Universal (CC0 1.0) Public Domain Dedication. The GenCC requests that you give attribution to GenCC and the contributing sources whenever possible and appropriate. The accepted Flagship manuscript is now available from Genetics in Medicine (https://www.gimjournal.org/article/S1098-3600(22)00746-8/fulltext).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. The GenCC does not independently verify the submitted information. Though the information is obtained from sources believed to be reliable, no warranty, expressed or implied, is made regarding accuracy, adequacy, completeness, reliability or usefulness of any information. This disclaimer applies to both isolated and aggregate uses of the information. The information is provided on an "as is" basis, collected through periodic submission and therefore may not represent the most up-to-date information from the submitters. If you have questions about the medical relevance of information contained on this website, please see a healthcare professional; if you have questions about specific gene-disease claims, please contact the relevant sources; and if you have questions about the representation of the data on this website, please contact gencc@thegencc.org.